Antithesis Ventures Fund I LP is a venture capital fund based in Washington, Dc, District of Columbia. Its most recent Form D, filed Apr 3, 2026, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include Alexander Shtarkman; Antithesis Ventures Fund I GP LLC.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- Alexander Shtarkman; Antithesis Ventures Fund I GP LLC
- Latest Form D
- Apr 3, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Antithesis Ventures Fund I LP
What is the minimum investment for Antithesis Ventures Fund I LP?
Antithesis Ventures Fund I LP's latest Form D, filed Apr 3, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Antithesis Ventures Fund I LP?
Antithesis Ventures Fund I LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has Antithesis Ventures Fund I LP raised?
Antithesis Ventures Fund I LP's latest Form D, filed Apr 3, 2026, reports no sales yet.
Where is Antithesis Ventures Fund I LP based?
Antithesis Ventures Fund I LP is based in Washington, Dc, District of Columbia.
Size compared with every venture capital fund
This fund hasn't reported any sales yet.